approval · primary record
EFLAPEGRASTIM-XNST
FDA · BLA · 2025-12-12
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-12-12 |
| Brand | ROLVEDON |
| Sponsor | SPECTRUM PHARMS |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:31.690Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:EFLAPEGRASTIM-XNST:2025-12-12
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.